Trials / Withdrawn
WithdrawnNCT03026647
Suture Material for Closure of Hysterotomy
Evaluation of Suture Material for Closure of Hysterotomy
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- St. Louis University · Academic / Other
- Sex
- Female
- Age
- 14 Years – 55 Years
- Healthy volunteers
- —
Summary
Retrospective chart review evaluating different suture types on surgical outcomes for cesarean delivery and vaginal birth after cesarean delivery outcomes when different sutures are used.
Detailed description
Cesarean sections are one of the most common surgeries performed in the United States; approximately 1 out of 3 births are completed by cesarean delivery. In 2014, 1,284,551 cesarean deliveries were performed. Unfortunately, even with this being a very common procedure some surgical topics have not been fully evaluated. One of these topics is the choice of suture for repair of the hysterotomy (uterine) incision. Several suture materials are available, yet only polygatactin-910 and catgut have been evaluated in a single study. In this study, only surgery complications were evaluated. Catgut was found to be associated with less risk of receiving a blood transfusion, otherwise no differences were found. One of the most common suture materials used at our institution is poliglecaprone 25, however no long term studies have been completed for this indication. In addition, no studies have evaluated the risk of uterine rupture with trial of labor after cesarean after using poliglecaprone 25 to repair the hysterotomy. This information could be very useful in counseling for patients. As the cesarean delivery rates continue to climb, information on appropriate technique for surgery are needed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Suture | To examine different types of suture material used for hysterotomy closure in cesarean section and determine if one is preferred above other types due to a complications profile. |
Timeline
- Start date
- 2017-01-31
- Primary completion
- 2018-04-01
- Completion
- 2018-05-01
- First posted
- 2017-01-20
- Last updated
- 2017-11-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03026647. Inclusion in this directory is not an endorsement.